CN103622964B - Trigolutesins A在治疗或预防急性心衰药物中的应用 - Google Patents
Trigolutesins A在治疗或预防急性心衰药物中的应用 Download PDFInfo
- Publication number
- CN103622964B CN103622964B CN201310643856.6A CN201310643856A CN103622964B CN 103622964 B CN103622964 B CN 103622964B CN 201310643856 A CN201310643856 A CN 201310643856A CN 103622964 B CN103622964 B CN 103622964B
- Authority
- CN
- China
- Prior art keywords
- heart failure
- trigolutesins
- treatment
- acute heart
- application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229930194390 trigolutesin Natural products 0.000 title claims abstract description 31
- 206010007556 Cardiac failure acute Diseases 0.000 title claims abstract description 18
- 239000003814 drug Substances 0.000 title claims abstract description 13
- 230000002265 prevention Effects 0.000 title claims description 12
- 238000002360 preparation method Methods 0.000 claims abstract description 11
- 150000001875 compounds Chemical class 0.000 claims description 13
- 206010019280 Heart failures Diseases 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 3
- 230000000747 cardiac effect Effects 0.000 description 8
- 241000282472 Canis lupus familiaris Species 0.000 description 5
- TYGUTURXHKSOBP-UHFFFAOYSA-N 10-bromo-5,12-dihydroindolo[2,3-g]carbazole-2,3-diol Chemical compound C1=C(Br)C=C2NC3=C(C4=C(C=C(C(=C4)O)O)N4)C4=CC=C3C2=C1 TYGUTURXHKSOBP-UHFFFAOYSA-N 0.000 description 3
- 241000282465 Canis Species 0.000 description 3
- 241000870682 Trigonostemon Species 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 229930187845 trigonostemon Natural products 0.000 description 3
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 210000000709 aorta Anatomy 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 229960002275 pentobarbital sodium Drugs 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000033240 Progressive symmetric erythrokeratodermia Diseases 0.000 description 1
- 208000006193 Pulmonary infarction Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229940022698 acetylcholinesterase Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 229940125758 compound 15 Drugs 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000003680 myocardial damage Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000007575 pulmonary infarction Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000002627 tracheal intubation Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310643856.6A CN103622964B (zh) | 2013-12-04 | 2013-12-04 | Trigolutesins A在治疗或预防急性心衰药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310643856.6A CN103622964B (zh) | 2013-12-04 | 2013-12-04 | Trigolutesins A在治疗或预防急性心衰药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103622964A CN103622964A (zh) | 2014-03-12 |
CN103622964B true CN103622964B (zh) | 2015-09-23 |
Family
ID=50204651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310643856.6A Active CN103622964B (zh) | 2013-12-04 | 2013-12-04 | Trigolutesins A在治疗或预防急性心衰药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103622964B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1832940A (zh) * | 2003-06-13 | 2006-09-13 | 詹森药业有限公司 | 用作激酶抑制剂的取代的吲唑基(吲哚基)马来酰亚胺衍生物 |
-
2013
- 2013-12-04 CN CN201310643856.6A patent/CN103622964B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1832940A (zh) * | 2003-06-13 | 2006-09-13 | 詹森药业有限公司 | 用作激酶抑制剂的取代的吲唑基(吲哚基)马来酰亚胺衍生物 |
Non-Patent Citations (1)
Title |
---|
Two New Types of Bisindole Alkaloid from Trigonostemon lutescens;Shan-Shan Ma et al;《Organic Letters》;20130312;第15卷(第7期);第1492-1495页 * |
Also Published As
Publication number | Publication date |
---|---|
CN103622964A (zh) | 2014-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103655549B (zh) | Myrtucommuacetalone在治疗或预防急性心衰药物中的应用 | |
CN103356669B (zh) | Houttuynoid A在制备治疗或预防急性心衰的药物中的应用 | |
CN103622964B (zh) | Trigolutesins A在治疗或预防急性心衰药物中的应用 | |
CN103494824B (zh) | Kadcoccitones A在制备治疗或预防急性心衰药物中的应用 | |
CN103751179B (zh) | 一种化合物在治疗或预防急性心衰药物中的应用 | |
CN105168191A (zh) | 一种治疗或预防急性心衰药物及其应用 | |
CN103372007B (zh) | Chukrasone B在制备治疗或预防急性心衰的药物中的应用 | |
CN105497039A (zh) | Trigonoliimines C在制备治疗或预防急性心衰药物中的应用 | |
CN103751176B (zh) | Trigoxyphin K在治疗或预防急性心衰药物中的应用 | |
CN105287504A (zh) | Irciniastatin B在制备治疗或预防急性心衰药物中的应用 | |
CN103356677B (zh) | Houttuynoid D在制备治疗或预防急性心衰的药物中的应用 | |
CN103356675B (zh) | Houttuynoid B在制备治疗或预防急性心衰的药物中的应用 | |
CN105287503A (zh) | Foveolide A在治疗或预防急性心衰药物中的应用 | |
CN103385886B (zh) | Houttuynoid E在制备治疗或预防急性心衰的药物中的应用 | |
CN105412081A (zh) | Penicillactones A在制备治疗或预防急性心衰药物中的应用 | |
CN103356683B (zh) | Houttuynoid C在制备治疗或预防急性心衰的药物中的应用 | |
CN105395537A (zh) | Vulgarisin A在治疗或预防急性心衰药物中的应用 | |
CN103462997A (zh) | Neonectrolide A在制备治疗或预防急性心衰药物中的应用 | |
CN106265649A (zh) | Ternatusine A在制备治疗或预防急性心衰药物中的应用 | |
CN106344567A (zh) | Ternatusine A在制备治疗或预防急性心衰药物中的应用 | |
CN103505456A (zh) | Racemosins A在制备治疗或预防急性心衰药物中的应用 | |
CN103285006A (zh) | Myriberine A在制备治疗或预防急性心衰药物中的应用 | |
CN102885836B (zh) | Gypensapogenin B在制备治疗或预防急性心衰的药物中的应用 | |
CN103251623A (zh) | Aspeverin在制备治疗或预防急性心衰药物中的应用 | |
CN102861034B (zh) | Gypensapogenin A在治疗或预防急性心衰的药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhao Guijuan Inventor after: Shao Yanshi Inventor after: Jia Yumei Inventor before: Li Qiang |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LI QIANG TO: ZHAO GUIJUAN SHAO YANSHI JIA YUMEI |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171017 Address after: 226561 Jiangsu province Nantong city Rugao city moves the town 1 villages Patentee after: Rugao afterburner hospital Address before: 266000 Shandong province Qingdao City Red Road No. 31 North Building 201 Patentee before: Li Qiang |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191212 Address after: 314407 No. 501, Sangzi South Road, zhouwangmiao Town, Haining City, Jiaxing City, Zhejiang Province Patentee after: Haining Qiantang New Rural Development Co., Ltd Address before: 226561 Jiangsu province Nantong city Rugao city moves the town 1 villages Patentee before: Rugao afterburner hospital |